George Institute for Global Health

The George Institute for Global Health
Established 1999 (1999)
Chairman Mike Hawker AM
Staff 450[1]
Location Sydney, Australia
Website www.thegeorgeinstitute.org

The George Institute for Global Health is an independent medical research institute dedicated to improving global health. The George Institute conducts high impact research that targets preventable illnesses and injuries that are the leading causes of death and disability worldwide, including heart and kidney disease, stroke, diabetes, and injury. It is ranked in the top 10 research institutions in the world for research impact by the SCImago Institutions Rankings World Reports.[2]

The George Institute conducts research in more than 50 countries, with bases in Australia, China, India and the UK. The Institute’s global network conducts research that provides healthcare solutions for hospitals, clinics and medical facilities serving millions of people around the world.

With a specific focus on the Asia Pacific regions, The Institute works to identify effective and affordable prevention and treatment strategies, and to strengthen health systems for disease and injury control through:

Since 1999, The George has invested over $250 million across 50 countries. With over 450 staff globally, The Institute collaborates with some of the world’s leading universities, health professionals, hospitals and governments.[7]

Areas of expertise include:

Founded by Professors Stephen MacMahon and Robyn Norton, The George is affiliated with the universities of Sydney, Peking, and Oxford.[13] The George Institute is currently chaired by Mike Hawker AM and The Institute’s board members are business and scientific leaders in both Australia and internationally.

The George employs world-leading scientific experts and has an enviable research track record. The George Institute is one of only three academic research organisations (ARO) accredited to run clinical trials, which ensure unbiased rigor and improved ability to disseminate findings, with the other two AROs being the University of Oxford in the UK and Duke University in the USA.

The institute has had major scientific outputs in publications including The Lancet,[14][15] The New England Journal of Medicine,[16][17] PLoS ONE Journal,[18] Heart (formerly British Heart Journal)[19] and more.[20]

References

  1. "History of The George Institute" Retrieved on 3 July 2015.
  2. Scimago Research Rankings Retrieved on 3 July 2015.
  3. "Joint Statement From The American Diabetes Association And American Association Of Clinical Endocrinologists". Medical News Today. 2009-03-25. Retrieved 2009-07-27.
  4. "Largest Ever Trial Conducted In Patients With Type 2 Diabetes Complete - "Advance Will Have Huge Implications For Care Of Patients Worldwide"". Medical News Today. 2008-05-22. Retrieved 2009-07-27.
  5. "Largest Ever Asian Smoking Study Reveals Cardiovascular Health Risks". Medical News Today. 2005-09-25. Retrieved 2008-07-21.
  6. Sinha, Kounteya (2007-09-05). "BP drugs cut stroke risk in diabetics". The Times of India. Retrieved 2008-07-21.
  7. "History of The George Institute" Retrieved on 3 July 2015.
  8. "Persistent Low-Back Pain Reduced By Motor Control Exercises". Medical News Today. 2009-01-29. Retrieved 2009-07-27.
  9. "Research Proves Tai Chi Benefits For Arthritis". Medical News Today. 2009-06-18. Retrieved 2009-07-27.
  10. "Back pain hurts 5 million Aussies". Science Alert. 2008-12-16. Retrieved 2009-07-27.
  11. "Stretching before workout 'a waste of time'". News.com.au. 2009-06-16. Retrieved 2009-07-27.
  12. "Back pain recovery is slow". Science Alert. 2008-07-08. Retrieved 2009-07-28.
  13. "Affiliates of The George Institute Retrieved on 3 July 2015.
  14. The Lancet ADVANCE study confirms blood pressure lowering benefits of type 2 diabetes patients. Retrieved on 20 April 2012.
  15. The Lancet Early results of major stroke trial, INTERACT, indicates hope for stroke patients. Retrieved 20 April 2012.
  16. The New England Journal of Medicine ADVANCE study highlights tight blood glucose control benefits for type 2 diabetes patients. Retrieved on 20 April 2012.
  17. The New England Journal of Medicine The SAFE TBI study provides critical information for intensive care units. Retrieved on 20 April 2012.
  18. PLoS ONE The POLYPILL provides hope for heart care all over the world. Retrieved on 20 April 2012.
  19. Heart First study of heart care in Chinese hospitals set to improve care of heart attack patients, CPACS. Retrieved on 20 April 2012.
  20. "The George Institute Publications". Retrieved on 3 July 2015.

External links

This article is issued from Wikipedia - version of the Thursday, February 18, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.